PL1638416T3 - Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej - Google Patents

Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej

Info

Publication number
PL1638416T3
PL1638416T3 PL04763015T PL04763015T PL1638416T3 PL 1638416 T3 PL1638416 T3 PL 1638416T3 PL 04763015 T PL04763015 T PL 04763015T PL 04763015 T PL04763015 T PL 04763015T PL 1638416 T3 PL1638416 T3 PL 1638416T3
Authority
PL
Poland
Prior art keywords
barrier function
nutritional formula
gut barrier
optimal gut
optimal
Prior art date
Application number
PL04763015T
Other languages
English (en)
Inventor
Clara Lucia Garcia-Rodenas
Gabriela Bergonzelli
Florence Rochat
Marco Enrico Turini
Irene Corthesy-Theulaz
Christine Cherbut
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PL1638416T3 publication Critical patent/PL1638416T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL04763015T 2003-06-23 2004-06-22 Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej PL1638416T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03014040 2003-06-23
PCT/EP2004/006736 WO2004112509A2 (en) 2003-06-23 2004-06-22 Nutritional formula for optimal gut barrier function
EP04763015.7A EP1638416B1 (en) 2003-06-23 2004-06-22 Use of a nutritional formula for optimal gut barrier function

Publications (1)

Publication Number Publication Date
PL1638416T3 true PL1638416T3 (pl) 2013-09-30

Family

ID=33522258

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04763015T PL1638416T3 (pl) 2003-06-23 2004-06-22 Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej

Country Status (10)

Country Link
US (1) US8394370B2 (pl)
EP (1) EP1638416B1 (pl)
CN (1) CN1863463B (pl)
AR (1) AR044888A1 (pl)
CA (1) CA2530437C (pl)
ES (1) ES2416287T3 (pl)
PL (1) PL1638416T3 (pl)
PT (1) PT1638416E (pl)
TW (1) TWI342779B (pl)
WO (1) WO2004112509A2 (pl)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
CA2570208A1 (en) * 2004-06-22 2005-12-29 N.V. Nutricia Improvement of barrier integrity in hiv patients
KR20070070153A (ko) 2004-06-23 2007-07-03 로레알 민감성 및/또는 건성 피부의 예방 및/또는 치료에 유용한방법 및 조성물
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
DK1841332T4 (da) 2004-11-18 2013-05-06 Nutricia Nv Fortykningsmiddelsammensætning til dysfagipatienter
BRPI0608782A2 (pt) * 2005-04-13 2010-01-26 Nestec Sa fórmula para bebê com probióticos
DK2258219T4 (da) * 2005-04-27 2022-08-29 Nutricia Nv Næring med lipider og ikke-fordøjelige saccharider
EP2270131A1 (en) 2005-05-31 2011-01-05 The Iams Company Feline probiotic lactobacilli
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
BRPI0611245A2 (pt) * 2005-06-06 2010-08-24 Bristol-Myers Squibb Company fàrmula infantil e seus usos
NO323665B1 (no) * 2005-06-27 2007-06-18 Pharmalogica As Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling.
PT1898724E (pt) * 2005-07-01 2010-11-26 Nutricia Nv Nutrição infantil com proteínas hidrolisadas
CA2623483A1 (en) 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
ATE451845T1 (de) * 2005-10-05 2010-01-15 Nestec Sa Verwendung einer nährstoffformulierung zur förderung des aufholwachstums
AU2015218488B2 (en) * 2005-10-21 2017-02-02 N.V. Nutricia Method for stimulating the intestinal flora
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
ES2381211T3 (es) * 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
CA2645472C (en) * 2006-03-10 2015-09-15 N.V. Nutricia Use of non-digestable saccharides for giving an infant the best start after birth
KR20090007407A (ko) * 2006-04-11 2009-01-16 마텍 바이오싸이언스스 코포레이션 장쇄 다중불포화 지방산을 포함하는 식품 제품 및 그의 제조 방법
NL1032840C2 (nl) * 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
CN105123950A (zh) * 2006-11-29 2015-12-09 普罗莱克塔生物科学公司 人乳组合物及其制备和使用方法
CN101631469B (zh) 2006-12-08 2014-04-02 普罗莱克塔生物科学公司 人类脂质组合物及其制备和使用方法
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
ES2668552T3 (es) * 2007-03-21 2018-05-18 Nestec S.A. Sistema de seguridad para composiciones nutricionales en polvo
JP2009102292A (ja) * 2007-04-27 2009-05-14 Chiba Prefecture ストレス抑制剤
EP1992351B1 (en) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
RU2486904C2 (ru) * 2007-11-08 2013-07-10 Нестек С.А. Применение олигосахаридов, содержащих n-ацетиллактозамин, для развития иммунных ответов у новорожденных
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
BRPI0821892A2 (pt) * 2008-01-28 2014-10-07 Mead Johnson Nutrition Co Composição nutricional contendo dha (ácido docosa-hexaenoico), ácido rumêncio e gangliosídeos
NL2001377C2 (nl) * 2008-03-14 2009-09-15 Friesland Brands Bv Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen.
US9439885B2 (en) * 2008-06-03 2016-09-13 Mead Johnson Nutrition Company Method for inhibiting the growth of bacteria
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
AR072141A1 (es) * 2008-06-13 2010-08-11 Nutricia Nv Composicion nutricional para lactantes nacidos por cesarea
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
EP2347661B1 (en) * 2008-11-21 2019-01-09 José Antonio Cruz Serrano Method for obtaining a mixture of probiotics, nutrient prebiotics having synergistic symbiotic action
JP2012510476A (ja) 2008-12-02 2012-05-10 プロラクタ バイオサイエンス，インコーポレイテッド ヒト乳透過組成物ならびにその製造および使用方法
CA2984935C (en) * 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
EP2418969B1 (en) * 2009-04-15 2013-03-06 N.V. Nutricia Anti-reflux infant nutrition
MX338680B (es) * 2009-05-11 2016-04-27 Nestec Sa Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
BR112012013766A2 (pt) 2009-12-08 2015-09-15 Nestec Sa "fórmula infantil com probióticos e componentes de membrana do glóbulo de gordura do leite"
NL2004201C2 (en) * 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
ES2536431T3 (es) 2010-04-26 2015-05-25 Enzymotec Ltd. Procedimientos y composiciones de lípidos para promover el desarrollo de la flora intestinal
WO2011136636A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant nutrition
CN102858191A (zh) * 2010-04-27 2013-01-02 N.V.努特里奇亚 6’-唾液酸化乳糖在婴儿和幼儿营养物中的用途
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2011148221A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Lactic acid bacteria for maturation of the enteric nervous system in infants
MX2013007736A (es) * 2010-12-29 2013-07-24 Nestec Sa Una composicion nutricional que comprende fibra y probioticos para reducir sintomas intestinales relacionados con estres.
US9283240B2 (en) 2010-12-31 2016-03-15 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
CN103763940B (zh) * 2010-12-31 2015-10-14 雅培制药有限公司 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
CA2822495C (en) 2010-12-31 2020-12-22 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
SG10201707519PA (en) 2010-12-31 2017-10-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
CN103501638A (zh) 2010-12-31 2014-01-08 雅培制药有限公司 包含人乳低聚糖和核苷酸的营养型组合物以及其治疗和/或预防肠病毒感染的用途
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
AU2012215042B2 (en) 2011-02-10 2016-01-14 Société des Produits Nestlé S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
EP2680866A1 (en) * 2011-03-01 2014-01-08 Quorum Innovations, LLC Materials and methods for treating conditions associated with pathogenic biofilm
AU2012241814A1 (en) * 2011-04-12 2013-10-03 Nestec S.A. Nutritional compositions including branched chain fatty acids for improving gut barrier function
EP3366143A1 (en) 2011-06-20 2018-08-29 H.J. Heinz Company Brands LLC Probiotic compositions and methods
BR112014000322A2 (pt) * 2011-07-12 2017-01-10 Nestec Sa "probióticos, e seus usos"
WO2013016111A1 (en) * 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CA2844045C (en) 2011-08-03 2018-05-08 Prolacta Bioscience, Inc. Microfiltration of human milk to reduce bacterial contamination
MX368124B (es) * 2011-08-29 2019-09-19 Abbott Lab Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
WO2013057062A1 (en) * 2011-10-18 2013-04-25 Nestec S.A. Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
ES2601891T3 (es) * 2011-10-18 2017-02-16 Nestec S.A. Composición para su uso en crecimiento cerebral y/o desarrollo cognitivo y/o psicomotor
WO2013126015A1 (en) * 2012-02-23 2013-08-29 N. V. Nutricia Composition comprising non- digestible oligosaccharides
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
US20140037813A1 (en) * 2012-08-02 2014-02-06 Mead Johnson Nutrition Company Nutritional creamer composition
EP2928325A1 (en) * 2012-12-10 2015-10-14 N.V. Nutricia Nutritional composition with non digestible oligosaccharides
MY187609A (en) * 2012-12-18 2021-10-04 Abbott Lab Human milk oligosaccharides to ameliorate symptoms of stress
US20140251944A1 (en) * 2013-03-08 2014-09-11 Nelson Jesus Spinetti Happy baby bottle
CN114794241A (zh) 2013-03-13 2022-07-29 普罗莱克塔生物科学公司 高脂人乳产品
US10568896B2 (en) 2013-11-19 2020-02-25 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
WO2015085549A1 (en) 2013-12-12 2015-06-18 Nestec S.A. An age-tailored nutrition system for an infant
CN104041906A (zh) * 2014-06-27 2014-09-17 施文康 一种断奶饮料的制作方法
US10617701B2 (en) * 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
JP7356221B2 (ja) 2015-12-30 2023-10-04 プロラクタ バイオサイエンス，インコーポレイテッド 術前及び術後のケアに有用なヒト乳製品
US20180103675A1 (en) * 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
CN108813262A (zh) * 2018-07-02 2018-11-16 杭州相生相成科技有限公司 一种含dha藻油的复合益生菌固体饮料
CN113194746A (zh) * 2018-12-21 2021-07-30 雀巢产品有限公司 用以改善胃肠屏障的包含人乳低聚糖的组合的营养组合物
IT201900000043A1 (it) * 2019-01-03 2020-07-03 Watt S R L Sostituto della prima colazione
WO2020156679A1 (en) * 2019-02-01 2020-08-06 Adisseo France S.A.S. Use of a thraustochytrid biomass for maintaining gut barrier function
WO2020229689A1 (en) 2019-05-15 2020-11-19 N.V. Nutricia Fermented formula for improving intestinal development
DK3979827T3 (da) 2019-06-04 2023-09-25 Nutricia Nv Næringssammensætning omfattende 2'fucosyllactose og 3'galactosyllactose
US20220079962A1 (en) * 2019-06-04 2022-03-17 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and dietary butyrate
CN110742275A (zh) * 2019-09-30 2020-02-04 北京斯利安药业有限公司 一种dha蛋黄粉及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
JPH0530942A (ja) * 1991-07-25 1993-02-09 Riyoushiyoku Kenkyukai 高分子の腸管透過性を制御する効果のある 飲食品及び医薬品
ATE160486T1 (de) 1991-08-12 1997-12-15 Nestle Sa Nahrungsmittelzusammensetzung
JP3002850B2 (ja) 1992-03-31 2000-01-24 雪印乳業株式会社 ガングリオシドｇｍ３配合栄養組成物
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6132710A (en) * 1997-03-17 2000-10-17 Probiotix, Inc. Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof
AU743914B2 (en) * 1997-07-05 2002-02-07 Societe Des Produits Nestle S.A. Absorption of minerals by intestinal cells
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
AUPP327198A0 (en) 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
CN1330542A (zh) 1998-12-15 2002-01-09 美国家用产品公司 对肠道完整性有维持和修复作用的方法与组合物
JP3411965B2 (ja) 1999-06-30 2003-06-03 雪印乳業株式会社 ポリアミン含有組成物の製造方法
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
IL151280A0 (en) * 2000-03-01 2003-04-10 Nestle Sa Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
JP3853673B2 (ja) 2001-03-09 2006-12-06 森永乳業株式会社 Ｃ型慢性肝炎治療剤
EP1281325A1 (en) 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Nutritional composition preventing bacterial overgrowth
AU2002339112B2 (en) * 2001-11-12 2007-10-11 Mars, Incorporated Foodstuff

Also Published As

Publication number Publication date
CN1863463B (zh) 2011-05-04
ES2416287T3 (es) 2013-07-31
TW200507863A (en) 2005-03-01
US8394370B2 (en) 2013-03-12
CA2530437A1 (en) 2004-12-29
WO2004112509A3 (en) 2006-08-03
TWI342779B (en) 2011-06-01
CN1863463A (zh) 2006-11-15
EP1638416A2 (en) 2006-03-29
PT1638416E (pt) 2013-07-08
EP1638416B1 (en) 2013-05-01
CA2530437C (en) 2011-11-15
WO2004112509A2 (en) 2004-12-29
AR044888A1 (es) 2005-10-05
US20070104700A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
PL1638416T3 (pl) Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
HK1139681A1 (en) Salts of valsartan
EP1699760A4 (en) ANTI-HYPERCHOLESTEROLEMIA COMPOUNDS
GB0324886D0 (en) Medicinal compounds
GB0303396D0 (en) Medicinal compounds
GB0305927D0 (en) Compound
IL174213A0 (en) A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
GB0306718D0 (en) Compound
AP2005003329A0 (en) Chemically acidified formula
GB0328490D0 (en) Medicinal compounds
GB0317841D0 (en) Compound
GB0317842D0 (en) Compound
GB0310361D0 (en) Pharmaceutical compound
EG23601A (en) A group of scessors for opening sermony
AU152187S (en) A trocar
GB0323215D0 (en) A spirometer
AU151660S (en) A wall plaque
AU151655S (en) A wall plaque
AU151656S (en) A wall plaque
AU151658S (en) A wall plaque
AU151659S (en) A wall plaque
AU151661S (en) A wall plaque
AU151657S (en) A wall plaque
AU151662S (en) A wall plaque
AU151654S (en) A wall plaque